Inogen
INGN
168 hedge funds and large institutions have $742M invested in Inogen in 2021 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 61 increasing their positions, 49 reducing their positions, and 34 closing their positions.
80% more call options, than puts
Call options by funds: $979K | Put options by funds: $544K
24% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 49
1.18% more ownership
Funds ownership: 94.87% → 96.06% (+1.2%)
0% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 34
1% less funds holding
Funds holding: 170 → 168 (-2)
20% less capital invested
Capital invested by funds: $924M → $742M (-$182M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$8.38M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$7.27M |
| 3 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$6.01M |
| 4 |
JGC
J. Goldman & Co
New York
|
+$5.45M |
| 5 |
Rockefeller Capital Management
New York
|
+$4.93M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$20.2M |
| 2 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
-$11.9M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$10.6M |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$10.4M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.57M |
INGN Hedge Fund Activity: Q4 2021 in Review
168 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Inogen (INGN) for Q4 2021, worth a combined $742M — down 20% from $924M a quarter earlier.
Fund positioning in INGN was balanced in Q4 2021: 34 funds opened new positions, 34 closed out, 61 added to existing stakes and 49 trimmed.
The largest buyer was BlackRock, adding an estimated $8.38M. The largest seller was Loomis, Sayles & Company, exiting entirely with an estimated $20.2M sold.
- 168 institutional investors held Inogen (INGN) as of Q4 2021, down from 170 in Q3 2021.
- Funds reported $742M of Inogen stock for Q4 2021, down 20% quarter-over-quarter.
- 34 funds opened new Inogen positions in Q4 2021 and 34 closed out, a net change of 0 holders.
- The largest Inogen buyer in Q4 2021 was BlackRock, an estimated $8.38M added.
- The largest Inogen seller in Q4 2021 was Loomis, Sayles & Company, an estimated $20.2M sold.
Based on aggregated 13F filings for Q4 2021.